nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CYP3A4—Imiquimod—skin cancer	0.102	0.292	CbGbCtD
Acetazolamide—CYP3A4—Temozolomide—skin cancer	0.102	0.292	CbGbCtD
Acetazolamide—CYP3A4—Vismodegib—skin cancer	0.0707	0.202	CbGbCtD
Acetazolamide—CYP3A4—Vemurafenib—skin cancer	0.0559	0.16	CbGbCtD
Acetazolamide—CA6—ear—skin cancer	0.0272	0.0951	CbGeAlD
Acetazolamide—CA3—ear—skin cancer	0.0257	0.0901	CbGeAlD
Acetazolamide—CYP3A4—Docetaxel—skin cancer	0.0192	0.0548	CbGbCtD
Acetazolamide—AQP1—endothelium—skin cancer	0.0188	0.0658	CbGeAlD
Acetazolamide—AQP1—blood vessel—skin cancer	0.0173	0.0607	CbGeAlD
Acetazolamide—Growth retardation—Dactinomycin—skin cancer	0.0165	0.0453	CcSEcCtD
Acetazolamide—CA6—hair follicle—skin cancer	0.0143	0.0501	CbGeAlD
Acetazolamide—AQP1—nipple—skin cancer	0.0125	0.0439	CbGeAlD
Acetazolamide—CA1—nerve—skin cancer	0.00908	0.0318	CbGeAlD
Acetazolamide—AQP1—connective tissue—skin cancer	0.00889	0.0311	CbGeAlD
Acetazolamide—AQP1—epithelium—skin cancer	0.00844	0.0296	CbGeAlD
Acetazolamide—AQP1—skin of body—skin cancer	0.00803	0.0281	CbGeAlD
Acetazolamide—Hyponatraemia—Vismodegib—skin cancer	0.00784	0.0215	CcSEcCtD
Acetazolamide—CA5A—female reproductive system—skin cancer	0.00753	0.0264	CbGeAlD
Acetazolamide—AQP1—mammalian vulva—skin cancer	0.00732	0.0256	CbGeAlD
Acetazolamide—Hypokalaemia—Vismodegib—skin cancer	0.0071	0.0195	CcSEcCtD
Acetazolamide—CA4—nerve—skin cancer	0.0071	0.0249	CbGeAlD
Acetazolamide—Tingling sensation—Imiquimod—skin cancer	0.00705	0.0193	CcSEcCtD
Acetazolamide—Reaction gastrointestinal—Docetaxel—skin cancer	0.00676	0.0185	CcSEcCtD
Acetazolamide—CA3—connective tissue—skin cancer	0.00652	0.0228	CbGeAlD
Acetazolamide—AQP1—lymphoid tissue—skin cancer	0.0065	0.0228	CbGeAlD
Acetazolamide—AQP1—female reproductive system—skin cancer	0.00627	0.022	CbGeAlD
Acetazolamide—Photosensitivity—Vemurafenib—skin cancer	0.00549	0.0151	CcSEcCtD
Acetazolamide—AQP1—head—skin cancer	0.00524	0.0183	CbGeAlD
Acetazolamide—Digestion impaired—Temozolomide—skin cancer	0.00508	0.0139	CcSEcCtD
Acetazolamide—CA2—hair follicle—skin cancer	0.00493	0.0173	CbGeAlD
Acetazolamide—Hepatic function abnormal—Imiquimod—skin cancer	0.00471	0.0129	CcSEcCtD
Acetazolamide—CA12—connective tissue—skin cancer	0.00462	0.0162	CbGeAlD
Acetazolamide—Dysgeusia—Vismodegib—skin cancer	0.0046	0.0126	CcSEcCtD
Acetazolamide—CA9—female reproductive system—skin cancer	0.0044	0.0154	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00434	0.0119	CcSEcCtD
Acetazolamide—CA6—head—skin cancer	0.00406	0.0142	CbGeAlD
Acetazolamide—CA4—nipple—skin cancer	0.00403	0.0141	CbGeAlD
Acetazolamide—CA4—neck—skin cancer	0.00399	0.014	CbGeAlD
Acetazolamide—Irritability—Imiquimod—skin cancer	0.00393	0.0108	CcSEcCtD
Acetazolamide—Tingling sensation—Fluorouracil—skin cancer	0.00389	0.0107	CcSEcCtD
Acetazolamide—CA3—head—skin cancer	0.00384	0.0135	CbGeAlD
Acetazolamide—Photosensitivity reaction—Vemurafenib—skin cancer	0.0038	0.0104	CcSEcCtD
Acetazolamide—Numbness—Fluorouracil—skin cancer	0.00377	0.0103	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00368	0.0101	CcSEcCtD
Acetazolamide—AQP1—lymph node—skin cancer	0.00367	0.0128	CbGeAlD
Acetazolamide—Sensory loss—Fluorouracil—skin cancer	0.00361	0.0099	CcSEcCtD
Acetazolamide—Aplastic anaemia—Dactinomycin—skin cancer	0.00352	0.00966	CcSEcCtD
Acetazolamide—CA5B—mammalian vulva—skin cancer	0.00341	0.0119	CbGeAlD
Acetazolamide—Dyspepsia—Vismodegib—skin cancer	0.00338	0.00926	CcSEcCtD
Acetazolamide—CA2—nipple—skin cancer	0.00334	0.0117	CbGeAlD
Acetazolamide—Decreased appetite—Vismodegib—skin cancer	0.00334	0.00914	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vismodegib—skin cancer	0.00331	0.00908	CcSEcCtD
Acetazolamide—Fatigue—Vismodegib—skin cancer	0.00331	0.00907	CcSEcCtD
Acetazolamide—CA2—neck—skin cancer	0.00331	0.0116	CbGeAlD
Acetazolamide—CA12—female reproductive system—skin cancer	0.00326	0.0114	CbGeAlD
Acetazolamide—Photosensitivity reaction—Imiquimod—skin cancer	0.00324	0.00889	CcSEcCtD
Acetazolamide—Aplastic anaemia—Temozolomide—skin cancer	0.00319	0.00874	CcSEcCtD
Acetazolamide—Erythema multiforme—Vemurafenib—skin cancer	0.00315	0.00865	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00314	0.00861	CcSEcCtD
Acetazolamide—Hepatic failure—Dactinomycin—skin cancer	0.00303	0.00831	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Imiquimod—skin cancer	0.003	0.00822	CcSEcCtD
Acetazolamide—CA5B—female reproductive system—skin cancer	0.00292	0.0102	CbGeAlD
Acetazolamide—Dysgeusia—Vemurafenib—skin cancer	0.00284	0.0078	CcSEcCtD
Acetazolamide—Asthenia—Vismodegib—skin cancer	0.00275	0.00755	CcSEcCtD
Acetazolamide—Hepatic failure—Temozolomide—skin cancer	0.00274	0.00752	CcSEcCtD
Acetazolamide—CA12—head—skin cancer	0.00272	0.00953	CbGeAlD
Acetazolamide—Erythema multiforme—Imiquimod—skin cancer	0.00269	0.00737	CcSEcCtD
Acetazolamide—CA3—lymph node—skin cancer	0.00269	0.00942	CbGeAlD
Acetazolamide—CA1—lymphoid tissue—skin cancer	0.00267	0.00937	CbGeAlD
Acetazolamide—Tinnitus—Imiquimod—skin cancer	0.00265	0.00727	CcSEcCtD
Acetazolamide—Flushing—Imiquimod—skin cancer	0.00264	0.00724	CcSEcCtD
Acetazolamide—Diarrhoea—Vismodegib—skin cancer	0.00263	0.0072	CcSEcCtD
Acetazolamide—Thirst—Temozolomide—skin cancer	0.00259	0.0071	CcSEcCtD
Acetazolamide—Photosensitivity—Fluorouracil—skin cancer	0.00259	0.00709	CcSEcCtD
Acetazolamide—CA1—female reproductive system—skin cancer	0.00258	0.00903	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00245	0.00673	CcSEcCtD
Acetazolamide—CA5B—head—skin cancer	0.00244	0.00855	CbGeAlD
Acetazolamide—Vomiting—Vismodegib—skin cancer	0.00244	0.00669	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vemurafenib—skin cancer	0.00237	0.0065	CcSEcCtD
Acetazolamide—CA2—connective tissue—skin cancer	0.00237	0.0083	CbGeAlD
Acetazolamide—Ataxia—Temozolomide—skin cancer	0.00232	0.00635	CcSEcCtD
Acetazolamide—Ill-defined disorder—Imiquimod—skin cancer	0.0023	0.0063	CcSEcCtD
Acetazolamide—Nausea—Vismodegib—skin cancer	0.00228	0.00625	CcSEcCtD
Acetazolamide—Agitation—Imiquimod—skin cancer	0.00228	0.00624	CcSEcCtD
Acetazolamide—CA2—epithelium—skin cancer	0.00225	0.00788	CbGeAlD
Acetazolamide—Hypokalaemia—Temozolomide—skin cancer	0.00224	0.00615	CcSEcCtD
Acetazolamide—Malaise—Imiquimod—skin cancer	0.00223	0.00612	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00222	0.00608	CcSEcCtD
Acetazolamide—Irritability—Fluorouracil—skin cancer	0.00217	0.00594	CcSEcCtD
Acetazolamide—CA1—head—skin cancer	0.00215	0.00755	CbGeAlD
Acetazolamide—Haematuria—Bleomycin—skin cancer	0.00215	0.00588	CcSEcCtD
Acetazolamide—Convulsion—Imiquimod—skin cancer	0.00215	0.00588	CcSEcCtD
Acetazolamide—CA2—skin of body—skin cancer	0.00214	0.0075	CbGeAlD
Acetazolamide—Ataxia—Fluorouracil—skin cancer	0.00214	0.00585	CcSEcCtD
Acetazolamide—Discomfort—Imiquimod—skin cancer	0.00208	0.00571	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00208	0.00571	CcSEcCtD
Acetazolamide—Decreased appetite—Vemurafenib—skin cancer	0.00206	0.00565	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00205	0.00561	CcSEcCtD
Acetazolamide—Fatigue—Vemurafenib—skin cancer	0.00204	0.0056	CcSEcCtD
Acetazolamide—CA4—female reproductive system—skin cancer	0.00202	0.00706	CbGeAlD
Acetazolamide—Hypoaesthesia—Bleomycin—skin cancer	0.00201	0.00551	CcSEcCtD
Acetazolamide—Shock—Imiquimod—skin cancer	0.00199	0.00545	CcSEcCtD
Acetazolamide—Agranulocytosis—Dactinomycin—skin cancer	0.00196	0.00537	CcSEcCtD
Acetazolamide—CA2—mammalian vulva—skin cancer	0.00195	0.00684	CbGeAlD
Acetazolamide—Photosensitivity reaction—Temozolomide—skin cancer	0.00194	0.00533	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00188	0.00516	CcSEcCtD
Acetazolamide—Flushing—Bleomycin—skin cancer	0.00188	0.00514	CcSEcCtD
Acetazolamide—Body temperature increased—Vemurafenib—skin cancer	0.00187	0.00514	CcSEcCtD
Acetazolamide—Hepatic failure—Docetaxel—skin cancer	0.00182	0.005	CcSEcCtD
Acetazolamide—Paraesthesia—Imiquimod—skin cancer	0.00182	0.00498	CcSEcCtD
Acetazolamide—Somnolence—Imiquimod—skin cancer	0.0018	0.00493	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Temozolomide—skin cancer	0.0018	0.00492	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Fluorouracil—skin cancer	0.00179	0.00491	CcSEcCtD
Acetazolamide—Erythema multiforme—Dactinomycin—skin cancer	0.00178	0.00489	CcSEcCtD
Acetazolamide—Dyspepsia—Imiquimod—skin cancer	0.00178	0.00488	CcSEcCtD
Acetazolamide—Decreased appetite—Imiquimod—skin cancer	0.00176	0.00482	CcSEcCtD
Acetazolamide—Flushing—Dactinomycin—skin cancer	0.00175	0.0048	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Imiquimod—skin cancer	0.00175	0.00478	CcSEcCtD
Acetazolamide—Fatigue—Imiquimod—skin cancer	0.00174	0.00478	CcSEcCtD
Acetazolamide—CA2—lymphoid tissue—skin cancer	0.00173	0.00607	CbGeAlD
Acetazolamide—CA5B—lymph node—skin cancer	0.00171	0.00598	CbGeAlD
Acetazolamide—Asthenia—Vemurafenib—skin cancer	0.0017	0.00466	CcSEcCtD
Acetazolamide—Hypoaesthesia—Temozolomide—skin cancer	0.0017	0.00465	CcSEcCtD
Acetazolamide—CA4—head—skin cancer	0.00168	0.0059	CbGeAlD
Acetazolamide—CA2—female reproductive system—skin cancer	0.00167	0.00585	CbGeAlD
Acetazolamide—Feeling abnormal—Imiquimod—skin cancer	0.00167	0.00457	CcSEcCtD
Acetazolamide—Hyponatraemia—Docetaxel—skin cancer	0.00165	0.00451	CcSEcCtD
Acetazolamide—Agranulocytosis—Fluorouracil—skin cancer	0.00163	0.00448	CcSEcCtD
Acetazolamide—Ill-defined disorder—Bleomycin—skin cancer	0.00163	0.00448	CcSEcCtD
Acetazolamide—Diarrhoea—Vemurafenib—skin cancer	0.00162	0.00445	CcSEcCtD
Acetazolamide—Erythema multiforme—Temozolomide—skin cancer	0.00161	0.00442	CcSEcCtD
Acetazolamide—Urticaria—Imiquimod—skin cancer	0.00161	0.0044	CcSEcCtD
Acetazolamide—Body temperature increased—Imiquimod—skin cancer	0.0016	0.00438	CcSEcCtD
Acetazolamide—Tinnitus—Temozolomide—skin cancer	0.00159	0.00436	CcSEcCtD
Acetazolamide—Malaise—Bleomycin—skin cancer	0.00159	0.00435	CcSEcCtD
Acetazolamide—Flushing—Temozolomide—skin cancer	0.00158	0.00434	CcSEcCtD
Acetazolamide—Leukopenia—Bleomycin—skin cancer	0.00158	0.00432	CcSEcCtD
Acetazolamide—Dizziness—Vemurafenib—skin cancer	0.00157	0.0043	CcSEcCtD
Acetazolamide—Hypoaesthesia—Fluorouracil—skin cancer	0.00156	0.00428	CcSEcCtD
Acetazolamide—Ataxia—Docetaxel—skin cancer	0.00154	0.00422	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—skin cancer	0.00152	0.00417	CcSEcCtD
Acetazolamide—CA1—lymph node—skin cancer	0.00151	0.00528	CbGeAlD
Acetazolamide—Vomiting—Vemurafenib—skin cancer	0.00151	0.00413	CcSEcCtD
Acetazolamide—Headache—Vemurafenib—skin cancer	0.00148	0.00407	CcSEcCtD
Acetazolamide—Discomfort—Bleomycin—skin cancer	0.00148	0.00406	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—skin cancer	0.00148	0.00406	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00148	0.00405	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—skin cancer	0.00147	0.00403	CcSEcCtD
Acetazolamide—Dysgeusia—Temozolomide—skin cancer	0.00145	0.00398	CcSEcCtD
Acetazolamide—Asthenia—Imiquimod—skin cancer	0.00145	0.00398	CcSEcCtD
Acetazolamide—Confusional state—Bleomycin—skin cancer	0.00145	0.00397	CcSEcCtD
Acetazolamide—Anaphylactic shock—Bleomycin—skin cancer	0.00144	0.00394	CcSEcCtD
Acetazolamide—Nausea—Vemurafenib—skin cancer	0.00141	0.00386	CcSEcCtD
Acetazolamide—Thrombocytopenia—Bleomycin—skin cancer	0.00141	0.00385	CcSEcCtD
Acetazolamide—CA2—head—skin cancer	0.0014	0.00489	CbGeAlD
Acetazolamide—Diarrhoea—Imiquimod—skin cancer	0.00138	0.00379	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—skin cancer	0.00138	0.00378	CcSEcCtD
Acetazolamide—Ill-defined disorder—Temozolomide—skin cancer	0.00138	0.00377	CcSEcCtD
Acetazolamide—Agitation—Temozolomide—skin cancer	0.00136	0.00374	CcSEcCtD
Acetazolamide—Malaise—Temozolomide—skin cancer	0.00134	0.00367	CcSEcCtD
Acetazolamide—Dizziness—Imiquimod—skin cancer	0.00134	0.00366	CcSEcCtD
Acetazolamide—Leukopenia—Temozolomide—skin cancer	0.00133	0.00364	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—skin cancer	0.00131	0.00359	CcSEcCtD
Acetazolamide—Paraesthesia—Bleomycin—skin cancer	0.00129	0.00353	CcSEcCtD
Acetazolamide—Convulsion—Temozolomide—skin cancer	0.00129	0.00353	CcSEcCtD
Acetazolamide—Vomiting—Imiquimod—skin cancer	0.00129	0.00352	CcSEcCtD
Acetazolamide—Headache—Imiquimod—skin cancer	0.00127	0.00347	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00125	0.00343	CcSEcCtD
Acetazolamide—Discomfort—Temozolomide—skin cancer	0.00125	0.00342	CcSEcCtD
Acetazolamide—Decreased appetite—Bleomycin—skin cancer	0.00125	0.00342	CcSEcCtD
Acetazolamide—Leukopenia—Fluorouracil—skin cancer	0.00122	0.00336	CcSEcCtD
Acetazolamide—Confusional state—Temozolomide—skin cancer	0.00122	0.00335	CcSEcCtD
Acetazolamide—Anaphylactic shock—Temozolomide—skin cancer	0.00121	0.00332	CcSEcCtD
Acetazolamide—Nausea—Imiquimod—skin cancer	0.0012	0.00329	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Docetaxel—skin cancer	0.00119	0.00327	CcSEcCtD
Acetazolamide—Thrombocytopenia—Temozolomide—skin cancer	0.00119	0.00325	CcSEcCtD
Acetazolamide—Convulsion—Fluorouracil—skin cancer	0.00118	0.00325	CcSEcCtD
Acetazolamide—Feeling abnormal—Bleomycin—skin cancer	0.00118	0.00324	CcSEcCtD
Acetazolamide—CA4—lymph node—skin cancer	0.00118	0.00413	CbGeAlD
Acetazolamide—Agranulocytosis—Docetaxel—skin cancer	0.00118	0.00323	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—skin cancer	0.00116	0.00319	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—skin cancer	0.00115	0.00317	CcSEcCtD
Acetazolamide—Discomfort—Fluorouracil—skin cancer	0.00115	0.00315	CcSEcCtD
Acetazolamide—Urticaria—Bleomycin—skin cancer	0.00114	0.00313	CcSEcCtD
Acetazolamide—Body temperature increased—Bleomycin—skin cancer	0.00114	0.00311	CcSEcCtD
Acetazolamide—Hypoaesthesia—Docetaxel—skin cancer	0.00113	0.00309	CcSEcCtD
Acetazolamide—Confusional state—Fluorouracil—skin cancer	0.00113	0.00308	CcSEcCtD
Acetazolamide—Anaphylactic shock—Fluorouracil—skin cancer	0.00112	0.00306	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—skin cancer	0.0011	0.00303	CcSEcCtD
Acetazolamide—Thrombocytopenia—Fluorouracil—skin cancer	0.00109	0.003	CcSEcCtD
Acetazolamide—Paraesthesia—Temozolomide—skin cancer	0.00109	0.00298	CcSEcCtD
Acetazolamide—CYP3A4—female reproductive system—skin cancer	0.00108	0.00378	CbGeAlD
Acetazolamide—Somnolence—Temozolomide—skin cancer	0.00108	0.00295	CcSEcCtD
Acetazolamide—Erythema multiforme—Docetaxel—skin cancer	0.00107	0.00294	CcSEcCtD
Acetazolamide—Dyspepsia—Temozolomide—skin cancer	0.00107	0.00292	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—skin cancer	0.00106	0.0029	CcSEcCtD
Acetazolamide—Decreased appetite—Temozolomide—skin cancer	0.00105	0.00289	CcSEcCtD
Acetazolamide—Flushing—Docetaxel—skin cancer	0.00105	0.00288	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Temozolomide—skin cancer	0.00105	0.00287	CcSEcCtD
Acetazolamide—Fatigue—Temozolomide—skin cancer	0.00104	0.00286	CcSEcCtD
Acetazolamide—Asthenia—Bleomycin—skin cancer	0.00103	0.00282	CcSEcCtD
Acetazolamide—Paraesthesia—Fluorouracil—skin cancer	0.001	0.00275	CcSEcCtD
Acetazolamide—Feeling abnormal—Temozolomide—skin cancer	0.000998	0.00274	CcSEcCtD
Acetazolamide—Somnolence—Fluorouracil—skin cancer	0.000992	0.00272	CcSEcCtD
Acetazolamide—Dyspepsia—Fluorouracil—skin cancer	0.000983	0.00269	CcSEcCtD
Acetazolamide—CA2—lymph node—skin cancer	0.000978	0.00343	CbGeAlD
Acetazolamide—Decreased appetite—Fluorouracil—skin cancer	0.00097	0.00266	CcSEcCtD
Acetazolamide—Dysgeusia—Docetaxel—skin cancer	0.000967	0.00265	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000964	0.00264	CcSEcCtD
Acetazolamide—Urticaria—Temozolomide—skin cancer	0.000962	0.00264	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—skin cancer	0.000961	0.00263	CcSEcCtD
Acetazolamide—Body temperature increased—Temozolomide—skin cancer	0.000958	0.00262	CcSEcCtD
Acetazolamide—Feeling abnormal—Fluorouracil—skin cancer	0.00092	0.00252	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—skin cancer	0.000916	0.00251	CcSEcCtD
Acetazolamide—Vomiting—Bleomycin—skin cancer	0.000913	0.0025	CcSEcCtD
Acetazolamide—Urticaria—Fluorouracil—skin cancer	0.000887	0.00243	CcSEcCtD
Acetazolamide—Leukopenia—Docetaxel—skin cancer	0.000884	0.00242	CcSEcCtD
Acetazolamide—Body temperature increased—Fluorouracil—skin cancer	0.000882	0.00242	CcSEcCtD
Acetazolamide—Asthenia—Temozolomide—skin cancer	0.000869	0.00238	CcSEcCtD
Acetazolamide—Convulsion—Docetaxel—skin cancer	0.000855	0.00234	CcSEcCtD
Acetazolamide—Nausea—Bleomycin—skin cancer	0.000853	0.00234	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—skin cancer	0.000852	0.00233	CcSEcCtD
Acetazolamide—Diarrhoea—Temozolomide—skin cancer	0.000829	0.00227	CcSEcCtD
Acetazolamide—Confusional state—Docetaxel—skin cancer	0.000812	0.00223	CcSEcCtD
Acetazolamide—Anaphylactic shock—Docetaxel—skin cancer	0.000806	0.00221	CcSEcCtD
Acetazolamide—Dizziness—Temozolomide—skin cancer	0.000801	0.0022	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—skin cancer	0.000796	0.00218	CcSEcCtD
Acetazolamide—Shock—Docetaxel—skin cancer	0.000793	0.00217	CcSEcCtD
Acetazolamide—Thrombocytopenia—Docetaxel—skin cancer	0.000789	0.00216	CcSEcCtD
Acetazolamide—Vomiting—Temozolomide—skin cancer	0.00077	0.00211	CcSEcCtD
Acetazolamide—Diarrhoea—Fluorouracil—skin cancer	0.000764	0.00209	CcSEcCtD
Acetazolamide—Headache—Temozolomide—skin cancer	0.000759	0.00208	CcSEcCtD
Acetazolamide—Dizziness—Fluorouracil—skin cancer	0.000738	0.00202	CcSEcCtD
Acetazolamide—Paraesthesia—Docetaxel—skin cancer	0.000723	0.00198	CcSEcCtD
Acetazolamide—Nausea—Temozolomide—skin cancer	0.00072	0.00197	CcSEcCtD
Acetazolamide—Somnolence—Docetaxel—skin cancer	0.000716	0.00196	CcSEcCtD
Acetazolamide—Vomiting—Fluorouracil—skin cancer	0.00071	0.00195	CcSEcCtD
Acetazolamide—Dyspepsia—Docetaxel—skin cancer	0.000709	0.00194	CcSEcCtD
Acetazolamide—Decreased appetite—Docetaxel—skin cancer	0.0007	0.00192	CcSEcCtD
Acetazolamide—Headache—Fluorouracil—skin cancer	0.000699	0.00192	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000696	0.00191	CcSEcCtD
Acetazolamide—Fatigue—Docetaxel—skin cancer	0.000695	0.0019	CcSEcCtD
Acetazolamide—Feeling abnormal—Docetaxel—skin cancer	0.000664	0.00182	CcSEcCtD
Acetazolamide—Nausea—Fluorouracil—skin cancer	0.000663	0.00182	CcSEcCtD
Acetazolamide—Body temperature increased—Docetaxel—skin cancer	0.000637	0.00175	CcSEcCtD
Acetazolamide—Asthenia—Docetaxel—skin cancer	0.000578	0.00158	CcSEcCtD
Acetazolamide—Diarrhoea—Docetaxel—skin cancer	0.000551	0.00151	CcSEcCtD
Acetazolamide—Dizziness—Docetaxel—skin cancer	0.000533	0.00146	CcSEcCtD
Acetazolamide—Vomiting—Docetaxel—skin cancer	0.000512	0.0014	CcSEcCtD
Acetazolamide—Headache—Docetaxel—skin cancer	0.000505	0.00138	CcSEcCtD
Acetazolamide—Nausea—Docetaxel—skin cancer	0.000479	0.00131	CcSEcCtD
